Conexeu Sciences Inc. disclosed the issuance of 1,448,368 unregistered shares of common stock and 202,500 unregistered common stock purchase warrants between June 18, 2026, and September 4, 2026. These transactions, which exceeded 5% of the company's outstanding common stock, were made pursuant to various consulting agreements, director compensation, and a warrant exercise incentive program.
Key Details
- Aggregate Issuances: A total of 1,448,368 common shares and 202,500 warrants were issued between June 18 and September 4, 2026.
- Warrant Exercise Proceeds: The company raised approximately $1.75 million in gross proceeds on September 4, 2026, from the issuance of 762,608 shares via its warrant exercise incentive program at a price of $2.30 per share.
- Use of Proceeds & Compensation: Proceeds from warrant exercises are intended for working capital. Other shares were issued as compensation for consulting, marketing, and board member services. All issued securities are restricted.